Zhejiang Garden Biopharmaceutical Co.,Ltd.

SZSE:300401 Stock Report

Market Cap: CN¥8.0b

Zhejiang Garden BiopharmaceuticalLtd Management

Management criteria checks 4/4

Zhejiang Garden BiopharmaceuticalLtd's CEO is Huanzheng Ma, appointed in Oct 2003, has a tenure of 21.08 years. directly owns 0.69% of the company’s shares, worth CN¥55.54M. The average tenure of the management team and the board of directors is 16.3 years and 3.8 years respectively.

Key information

Huanzheng Ma

Chief executive officer

CN¥1.0m

Total compensation

CEO salary percentagen/a
CEO tenure21.1yrs
CEO ownership0.7%
Management average tenure16.3yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

Zhejiang Garden BiopharmaceuticalLtd's (SZSE:300401) Profits May Not Reveal Underlying Issues

Oct 24
Zhejiang Garden BiopharmaceuticalLtd's (SZSE:300401) Profits May Not Reveal Underlying Issues

Zhejiang Garden BiopharmaceuticalLtd (SZSE:300401) Has A Somewhat Strained Balance Sheet

Sep 29
Zhejiang Garden BiopharmaceuticalLtd (SZSE:300401) Has A Somewhat Strained Balance Sheet

Zhejiang Garden Biopharmaceutical Co.,Ltd.'s (SZSE:300401) Stock Retreats 26% But Earnings Haven't Escaped The Attention Of Investors

Sep 08
Zhejiang Garden Biopharmaceutical Co.,Ltd.'s (SZSE:300401) Stock Retreats 26% But Earnings Haven't Escaped The Attention Of Investors

Why Investors Shouldn't Be Surprised By Zhejiang Garden Biopharmaceutical Co.,Ltd.'s (SZSE:300401) 27% Share Price Surge

Jun 30
Why Investors Shouldn't Be Surprised By Zhejiang Garden Biopharmaceutical Co.,Ltd.'s (SZSE:300401) 27% Share Price Surge

Is Zhejiang Garden BiopharmaceuticalLtd (SZSE:300401) A Risky Investment?

May 31
Is Zhejiang Garden BiopharmaceuticalLtd (SZSE:300401) A Risky Investment?

Subdued Growth No Barrier To Zhejiang Garden Biopharmaceutical Co.,Ltd. (SZSE:300401) With Shares Advancing 27%

May 06
Subdued Growth No Barrier To Zhejiang Garden Biopharmaceutical Co.,Ltd. (SZSE:300401) With Shares Advancing 27%

Why Zhejiang Garden BiopharmaceuticalLtd's (SZSE:300401) Shaky Earnings Are Just The Beginning Of Its Problems

Apr 22
Why Zhejiang Garden BiopharmaceuticalLtd's (SZSE:300401) Shaky Earnings Are Just The Beginning Of Its Problems

CEO

Huanzheng Ma (59 yo)

21.1yrs

Tenure

CN¥1,011,900

Compensation

Mr. Huanzheng Ma serves as General Manager and Vice Chairman of Zhejiang Garden Biopharmaceutical Co.,Ltd.(Formerly known as Zhejiang Garden Bio-chemical High-tech Co., Ltd.) since October 10, 2003.


Leadership Team

NamePositionTenureCompensationOwnership
Huanzheng Ma
Vice Chairman & GM21.1yrsCN¥1.01m0.69%
CN¥ 55.5m
Quanheng Yu
VP, Secretary to the Board & Directorno dataCN¥700.00k0.52%
CN¥ 41.7m
Xiao Ping Liu
Deputy General Manager21.1yrsCN¥370.00k0.071%
CN¥ 5.7m
Jiangang Liu
Executive Deputy General Manager16.3yrsCN¥780.90k0.24%
CN¥ 19.5m
Chunhua Wu
CFO & Financial Director8.6yrsCN¥573.20kno data
Guoping Qian
Deputy General Manager11.3yrsCN¥716.90k0.093%
CN¥ 7.5m

16.3yrs

Average Tenure

54yo

Average Age

Experienced Management: 300401's management team is seasoned and experienced (16.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Huanzheng Ma
Vice Chairman & GM21.1yrsCN¥1.01m0.69%
CN¥ 55.5m
Quanheng Yu
VP, Secretary to the Board & Director16.5yrsCN¥700.00k0.52%
CN¥ 41.7m
Qin Xiang Shao
Director21.1yrsno datano data
Xujun Shao
Chairman of the Board3.8yrsCN¥1.10m0.45%
CN¥ 36.3m
Yiping Shao
Independent Director3.8yrsCN¥100.00kno data
Jianmiao Yan
Independent Director3.8yrsCN¥100.00kno data
Xiangqian Ren
Chairman of the Supervisory Board7yrsno datano data
Can Jin
Independent Director3.8yrsCN¥100.00kno data
Zhonglan Wei
Vice Chairman2.6yrsCN¥1.04mno data
Fusheng Fang
Director2.6yrsCN¥964.40kno data
Qiwei Yang
Independent Directorless than a yearno datano data
Guowei Li
Independent Directorless than a yearno datano data

3.8yrs

Average Tenure

55.5yo

Average Age

Experienced Board: 300401's board of directors are considered experienced (3.8 years average tenure).